Dow Down 0.22% Nasdaq Up 0.14%

More On OXB.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Oxford BioMedica PLC (OXB.L)

-LSE
3.69 Up 0.19(5.43%) Aug 22, 10:53AM EDT
Prev Close:3.50
Open:3.50
Bid:3.50
Ask:3.75
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:3.49 - 3.69
52wk Range:1.40 - 3.80
Volume:2,111,958
Avg Vol (3m):1,843,270
Market Cap:52.26M
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

» More Headlines for OXB.L

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):922.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines for the treatment of cancer, and age-related or inherited neurodegenerative disorders and ocular diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback